News | Cureline, Inc

Jan 06, 2026 ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery

Combination creates expanded scientific and geographic footprint to meet growing client demand for biospecimens

Aug 01, 2023 Cureline, Inc. Celebrates 20 Years of Excellence in Biobanking and Translation R&D.

Cureline, Inc. Celebrates 20 Years of Excellence in Biobanking and Translation R&D.

May 31, 2023 THE CURELINE GROUP and PALLEOS HEALTHCARE ANNOUNCE A STRATEGIC PARTNERSHIP TO COMBINE PRECLINICAL AND CLINICAL SERVICES

The Cureline Group, and palleos healthcare, today announced a strategic partnership to offer end-to-end solutions for medical innovation.

Mar 20, 2023 Newsweek Special Report 2023 on - The New Era of Life Sciences - features Olga Potapova, PhD. Read how Dr Potapova and her team at Cureline help shape the industry's future.

Nov 10, 2022 THE CURELINE GROUP and CELLECTA, Inc Partner to Launch Tissue 2 Target™ Services

Sep 26, 2022 Cureline Group conference in Turkey a rousing success

Aug 04, 2022 Cureline Baltic COO Agne Vaitkeviciene has presented Cureline Group - Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022.

Jun 03, 2022 Cureline and Olga Potapova, PhD are featured in the 2022 edition of US Life Sciences 2022 Report:

Cureline and Olga Potapova, PhD are featured in the 2022 edition of US Life Sciences 2022 Report:

Feb 25, 2021 Cureline and Scientist.com Webinar on Human Biospecimens Regulations in India

Cureline VP of Biospecimens Operations., Dr. Harminder Singh, and our Lead Consultant, Dr. Birendra Yadav, are discussing the India HBS regulations with the Scientist.com platform users.

Feb 03, 2021 Leading human biospecimen CRO Cureline to establish research team in Lithuania

Cureline, a US-based provider of human biospecimens (HBS) to the global biomedical research community, is establishing a clinical operations and research team in Lithuania.

Blog/News